Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2012
03/15/2012US20120064157 Pharmaceutical composition and administrations thereof
03/15/2012US20120064155 Oral pharmaceutical composition for use in respiratory diseases
03/15/2012US20120064147 Agent for improving tissue penetration
03/15/2012US20120064126 Dry powder formulations and methods for treating pulmonary diseases
03/15/2012US20120064121 Pyridine compounds for inflammation and immune-related uses
03/15/2012US20120064086 High concentration antibody and protein formulations
03/15/2012US20120064073 Il-17 homologous polypeptides and therapeutic uses thereof
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
03/15/2012US20120064050 Tissue Engineering of Lung
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012US20120060834 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
03/15/2012DE102010040705A1 Blütenextrakt von Primula flos zur Behandlung und Prophylaxe von Entzündungen oder viralen Infektionen Primula flower extract of flos for the treatment and prophylaxis of infections or viral infections
03/15/2012CA2842454A1 Nasal spray
03/15/2012CA2812034A1 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012CA2810489A1 Prostaglandin d synthase inhibitory piperidine compounds
03/14/2012EP2428217A1 Composition based on docosahexaenoic acid (dha) for use in the treatment of cystic fibrosis and non-alcoholic hepatic steatosis
03/14/2012EP2427445A1 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
03/14/2012EP2029600B1 Substituted pteridines substituted with a four-membered heterocycle
03/14/2012EP1546194B1 Therapeutic uspa1-derived peptides
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1471895B2 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
03/14/2012CN202161677U 一种中药治疗肺经组织疾病的装置 A traditional Chinese medicine treatment device lung tissue disease
03/14/2012CN1939445B Preparation and use for loquat-leaf extract
03/14/2012CN1939444B Preparation and use for loquat-shell aqueous extract
03/14/2012CN102378814A Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
03/14/2012CN102378757A Pyrimidine compound
03/14/2012CN102378753A Plasminogen activator inhibitor-1 inhibitor
03/14/2012CN102373184A Avian influenza and infectious bronchitis hybrid virus-like particle as well as preparation method and application thereof
03/14/2012CN102372730A Bridged ring substituted phosphodiesterase inhibitor
03/14/2012CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors
03/14/2012CN102370984A Inhalation medicinal composition prepared from eplerenone and glucocorticoid serving as active ingredients
03/14/2012CN102370972A Compound Chinese medicine composition for treating infectious bronchitis of chicken and preparation method thereof
03/14/2012CN102370968A Compound propolis composite for treating chicken infectious laryngotracheitis and preparation method thereof
03/14/2012CN102370961A Chinese herbal medicine for treating celostomia caused by coughing
03/14/2012CN102370959A Traditional Chinese medicine composition for treating nasosinusitis
03/14/2012CN102370954A Medicine for treating chronic rhinitis
03/14/2012CN102370921A Detection method of strong loquat dew traditional Chinese preparation
03/14/2012CN102370900A Traditional Chinese medicine mixture for treating pertussis
03/14/2012CN102370890A Traditional Chinese medicine for treating chronic pharyngitis
03/14/2012CN102370889A Chinese herbal medicine for curing chronic bronchitis associated with chronic pulmonary diseases
03/14/2012CN102370875A Effervescing agent for relieving cough and reducing sputum and preparation method thereof
03/14/2012CN102370873A Medicament for treating chronic pharyngitis
03/14/2012CN102370871A Preparation method of cough-relieving Sichuan fritillary bulb-loguat oral liquid
03/14/2012CN102370870A Preparation method of cough treating bulbus fritilariae loquat slow-released tablet
03/14/2012CN102370869A Cough treating bulbus fritilariae loquat capsule and preparation method thereof
03/14/2012CN102370868A Herbal powder for hyperpyrexia
03/14/2012CN102370863A Traditional Chinese medicine for treating bronchial asthma
03/14/2012CN102370812A Method for detecting antiphlogistic and antipyretic particles
03/14/2012CN102370810A Compound artemisia rupestris capsule and preparation method thereof
03/14/2012CN102370808A Chinese medicine injection for treating porcine respiratory disease
03/14/2012CN102370799A Traditional Chinese medicine decoction for treating head erysipelas
03/14/2012CN102370783A Application of traditional Chinese drug composition in preparation of drugs for treating lung injury caused by smoking
03/14/2012CN102370770A Self-heating traditional Chinese medicine emplastrum for treating asthma
03/14/2012CN102370720A Desensitization paste for treating rhinitis
03/14/2012CN102370704A Compound camellia seed essential oil
03/14/2012CN102370692A Isatis root medicinal composition and preparation method thereof
03/14/2012CN102370685A Chinese medicinal decoction for treating throat and stomach diseases
03/14/2012CN102370683A Rhinitis treating paste
03/14/2012CN102370677A Three-flavor sandalwood preparation and preparation method thereof
03/14/2012CN102370670A Efficient processing method of Chinese caterpillar fungus
03/14/2012CN102370664A Paracetamol-caffeine-artificial cow-bezoar-chlorphenamine maleate medicinal composition and preparation method thereof
03/14/2012CN102370656A Clarithromycin medicine composition and preparation method thereof
03/14/2012CN102370654A Inhalation pharmaceutical composition with eplerenone and momestasone furoate as active components
03/14/2012CN102370653A Application of eplerenone in preparing medicaments for treating pulmonary fibrosis
03/14/2012CN102370652A Inhaled pharmaceutical composition containing eplerenone and budesonide as active components
03/14/2012CN102370651A Inhaled pharmaceutical composition containing eplerenone and ciclesonide as active components
03/14/2012CN102370620A Pulmonic targeting immuno nano liposome and preparation method thereof
03/14/2012CN101904859B Rhoifolin and hyperin composition and application of medicines prepared therefrom
03/14/2012CN101836952B Ambroxol injection and preparation method thereof
03/14/2012CN101708238B Preparation method of qingkailing syrup
03/14/2012CN101632804B Quality control method for wind-dispelling heat-dissipating capsules
03/14/2012CN101361739B Anti-bacteria agent for parenteral administration
03/14/2012CN101284016B Bezoar vitro bred and solid oral preparation containing the bezoar
03/14/2012CN101284008B IL-4R antagonist and microorganism for generating the IL-4R antagonist
03/14/2012CN101219188B Anti-inflammation antalgica liquid
03/13/2012US8133972 IgE antigenic peptides
03/13/2012US8133728 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012US8133726 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012US8133502 System for delivering a composition to the nasal membrane and method of using same
03/13/2012CA2676670C Tricyclic compounds, compositions, and methods
03/13/2012CA2643097C Amine derivatives
03/13/2012CA2515574C Aminophosphonic acid derivative, salt thereof, and modulator of s1p receptor
03/13/2012CA2503212C Matieres pour filtres a eau et filtres a eau contenant un melange de particules de carbone microporeuses et mesoporeuses
03/13/2012CA2467159C Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
03/13/2012CA2356779C Cytokine receptor chain
03/13/2012CA2238080C A novel haemopoietin receptor and genetic sequences encoding same
03/08/2012WO2012030664A1 Dry powder formulations and methods for treating pulmonary diseases
03/08/2012WO2012030647A1 Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
03/08/2012WO2012030645A1 Respirably dry powder comprising calcium lactate, sodium chloride and leucine
03/08/2012WO2012030513A2 Methods of treating bacterial infections through pulmonary delivery of fusidic acid
03/08/2012WO2012028663A1 Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
03/08/2012WO2012028662A1 Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
03/08/2012WO2012028614A1 5-ht2b receptor antagonists
03/08/2012WO2011140550A3 Immunogen adherence and method of making and using same
03/08/2012WO2011123179A3 Alkylated sp-c peptoid compounds and related surfactant compositions
03/08/2012WO2003032894A3 Method of monitoring neuroprotective treatment
03/08/2012US20120059176 Anti-inflammatory modalities
03/08/2012US20120059061 Novel anti-inflammatory compounds
03/08/2012US20120059055 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
03/08/2012US20120059034 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation